[Recent studies on the in vivo and in vitro activity of gentamicin].
The effect of gentamycin was investigated at the University of Modena Phthisiology and Respiratory Diseases Department. In vitro activity against most pathological Gram-positive and Gram-negative bacteria was observed. A dose of 4-5 mg/kg proved very effective in cases of bacteria-induced bronchopneumopathy. The drug was also active against penicillin-resistant staphylococci and Gram-negative bacteria with a known resistance to ordinary antibiotics.
D000150:Acinetobacter / Q000187:drug effects; D000328:Adult; D000368:Aged; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D004341:Drug Evaluation; D005839:Gentamicins / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D012131:Respiratory Insufficiency / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*
D005839:Gentamicins
Ulteriori osservazioni sull'attività "in vitro" e "in vivo" della gentamicina